SCHEMBL10264353

SCHEMBL10264353

CBCCCCC1(C(=O)OCC)CCC1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.43
CYP4A11 Q02928 1/20 0.43
LMNA P02545 2/20 0.39
POLB P06746 2/20 0.39
PKM P14618 2/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 8/20 0.37
MEN1 O00255 7/20 0.37
ALDH1A1 P00352 9/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
MAPK1 P28482 1/20 0.35
NPY1R P25929 1/20 0.35
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2737125 0.84 CYP4F2 (0.43) CYP4F2CYP4A11POLBPKMKMT2A
SCHEMBL22098179 0.82 CYP4F2 (0.63) CYP4F2CYP4A11LMNAPOLBPKM
SCHEMBL8071102 0.82 CYP4F2 (0.45) CYP4F2CYP4A11LMNAPOLBPKM
SCHEMBL186582 0.81 CYP4F2 (0.45) CYP4F2CYP4A11LMNAPOLBPKM
SCHEMBL1106769 0.81 CYP4F2 (0.45) CYP4F2CYP4A11LMNAPOLBPKM
SCHEMBL186204 0.81 CYP4F2 (0.45) CYP4F2CYP4A11LMNAPOLBPKM
SCHEMBL187550 0.81 CYP4F2 (0.45) CYP4F2CYP4A11LMNAPOLBPKM
SCHEMBL798044 0.79 CYP4F2 (0.53) CYP4F2CYP4A11LMNAPOLBPKM
SCHEMBL24525804 0.79 CYP4F2 (0.54) CYP4F2CYP4A11LMNAPOLBPKM
SCHEMBL1660144 0.79 CYP4F2 (0.42) CYP4F2CYP4A11LMNAPOLBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2404890-A1 Hydroxyl compounds and compositions for cholesterol management and related uses Esperion Therapeutics Inc. (US) 2012-01-11 EP disclosed